SCHEMBL7475389

SCHEMBL7475389

NCCCCCC(N)CCCN

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DNM1 Q05193 5/20 0.50
CA12 O43570 2/20 0.50
CA1 P00915 2/20 0.50
CA2 P00918 2/20 0.50
CA3 P07451 2/20 0.50
CA4 P22748 2/20 0.50
CA6 P23280 2/20 0.50
CA5A P35218 2/20 0.50
CA7 P43166 2/20 0.50
CA9 Q16790 2/20 0.50
CA14 Q9ULX7 2/20 0.50
CA5B Q9Y2D0 2/20 0.50
TSHR P16473 2/20 0.50
LMNA P02545 1/20 0.50
BLM P54132 1/20 0.50
GSR P00390 1/20 0.44
NFKB1 P19838 1/20 0.44
MEN1 O00255 1/20 0.38
KMT2A Q03164 1/20 0.38
ALDH1A1 P00352 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11021472 1.00 DNM1 (0.50) DNM1CA12CA1CA2CA3
SCHEMBL27909365 1.00 DNM1 (0.50) DNM1CA12CA1CA2CA3
SCHEMBL19328394 1.00 DNM1 (0.50) DNM1CA12CA1CA2CA3
SCHEMBL3792319 1.00 DNM1 (0.50) DNM1CA12CA1CA2CA3
SCHEMBL352357 0.97 DNM1 (0.53) DNM1CA12CA1CA2CA3
SCHEMBL349469 0.97 DNM1 (0.53) DNM1CA12CA1CA2CA3
SCHEMBL16696692 0.97 DNM1 (0.53) DNM1CA12CA1CA2CA3
SCHEMBL20597340 0.97 DNM1 (0.53) DNM1CA12CA1CA2CA3
SCHEMBL350445 0.97 DNM1 (0.53) DNM1CA12CA1CA2CA3
SCHEMBL351414 0.97 NFKB1 (0.47) DNM1CA12CA1CA2CA3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1198492-A1 ZWITTERIONIC POLYAMINES AND A PROCESS FOR THEIR PRODUCTION BASF AKTIENGESELLSCHAFT (DE) 2002-04-24 EP claimed
WO-2001005874-A1 ZWITTERIONIC POLYAMINES AND A PROCESS FOR THEIR PRODUCTION BASF AKTIENGESELLSCHAFT (DE) 2001-01-25 WO claimed
US-20230139979-A1 ORGANIC AMINE COLLECTION METHOD ASAHI KASEI KABUSHIKI KAISHA (JP) 2023-05-04 US disclosed
EP-4171494-A1 METHODS FOR PREPARATION OF KERATIN FIBER COLOR COATINGS WITH A CARBOXYLIC ACID POLYMER - CDI COMPOSITION Wella Germany GmbH (DE) 2023-05-03 EP disclosed
US-11578030-B2 Organic amine collection method ASAHI KASEI KABUSHIKI KAISHA (JP) 2023-02-14 US disclosed
US-20210155573-A1 ORGANIC AMINE COLLECTION METHOD ASAHI KASEI KABUSHIKI KAISHA (JP) 2021-05-27 US disclosed
EP-3733644-A1 ORGANIC AMINE COLLECTION METHOD Asahi Kasei Kabushiki Kaisha (JP) 2020-11-04 EP disclosed
CN-1157363-C Process for preparing amines from compounds with at least 3 cyano �����ɷ� 2004-07-14 CN disclosed
EP-1198492-A1 ZWITTERIONIC POLYAMINES AND A PROCESS FOR THEIR PRODUCTION BASF AKTIENGESELLSCHAFT (DE) 2002-04-24 EP disclosed
WO-2001029112-A1 PROCESS FOR THE PRODUCTION OF ZWITTERIONIC POLYAMINES BASF AKTIENGESELLSCHAFT (DE) 2001-04-26 WO disclosed
WO-2001005874-A1 ZWITTERIONIC POLYAMINES AND A PROCESS FOR THEIR PRODUCTION BASF AKTIENGESELLSCHAFT (DE) 2001-01-25 WO disclosed
CN-1169713-A Process for preparing amines from compounds containing at least three cyano groups BASF AG (DE) 1998-01-07 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230139979-A1 ORGANIC AMINE COLLECTION METHOD H1-0, F12, C1S DNM1 2684/4885CA12 209/4885CA1 120/4885
US-11578030-B2 Organic amine collection method H1-0, C1S, NGLY1 DNM1 2658/4885CA12 174/4885CA1 136/4885
US-20210155573-A1 ORGANIC AMINE COLLECTION METHOD H1-0, C1S, NGLY1 DNM1 2658/4885CA12 174/4885CA1 136/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.